Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Based on an FDA analysis, HHS said cannabis passed its alternative test for "accepted medical use" and, after reconsidering its "potential for abuse," recommended placing it in Schedule III.
Simplified Text
Based on an FDA analysis, the Department of Health and Human Services (HHS) stated that cannabis met its alternative "accepted medical use" test and recommended its placement in Schedule III.
Confidence Score
0.900
Claim Maker
The author
Context Type
News Article
Subject Tags
Regulation FDA HHS Drug Policy
UUID
9f2a69db-03ea-421f-abcd-f769ae1bb583
Vector Index
✗ No vector
Created
September 30, 2026 at 10:01 PM (1 week ago)
Last Updated
September 30, 2026 at 10:01 PM (1 week ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://reason.com/2026/09/30/hazy-federal-criteria-for-classifying-drugs-invite-arbitrary-bureaucratic-judgments
Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments
Completed Analysis
10 claims 🔥
1 week ago
https://reason.com/2026/09/30/hazy-federal-criteria-for-classifying-drugs-invite-arbitrary-bureaucratic-judgments

A GAO report notes that the Controlled Substances Act (CSA) does not define "potential for abuse" or "accepted medical use," leading to arbitrary bureaucratic judgments. This lack of clarity has significant criminal justice implications, as seen in the historical treatment of cannabis.

Drug Policy Controlled Substances Act Drug Classification Government Accountability Office DEA FDA Cannabis Reclassification

Similar Claims (5)

Other claims identified as semantically similar to this one.